Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Transcriptional regulatory dynamics underlying neuroinflammation-associated states of microglia

  • Navarrón, Carmen M.
Programa de Doctorado en Neurociencias por la Universidad Miguel Hernández de Elche (IN-CSIC)., [EN] Microglia heterogeneity has been shown in both healthy and chronic neurodegenerative conditions, however, very little is known about microglia chromatin accessibility and transcriptome landscape during acute neuroinflammation. We combined bulk RNAsequencing and ATAC-sequencing on FACS-sorted microglia population with single molecule in situ hybridization (RNAscope), to reveal dynamic transitions across microglia functional states along the acute neuroinflammatory response. We identify an immediateearly cytokine-related (Il1b) and an immediate-sustained interferon response (Oasl2) microglia; a delayed response associated to heterogeneous proliferative microglia (Ms4a4a); and a delayed-sustained late stage of MHC-II-expressing (Axl) microglia; altogether with a transient loss of homeostatic genes (P2ry12, Cx3cr1 among others). Meta-analysis of published DAM microglia marker genes and LPS-responsive microglia shows that late stage of acute inflammation-associated microglia shares DAM phenotype. We confirm the presence of DAM and IRM microglia by microglia single-cell RNA-sequencing of J20 mouse model of AD. Moreover, we identify in situ by RNAscope of common acute and chronic neuroinflammation marker genes, a specific upregulation of the interferon-related marker (Oasl2) in the proximity of diffuse Aβ plaques whereas the phagocytic-related marker (Axl) is expressed by microglia in the surrounding of both dense and diffuse Aβ plaques. We also revealed an increase in the expression of both Oasl2 and Axl in human postmortem brain tissue from AD patients. Finally, in silico transcription factor motif analysis shows the RelA/p65 subunit of the transcription factor NF-κB as a key regulator of microglia cytokine-related transcriptional program. Conditional depletion of RelA in microglia during adulthood (RelA-cKO mice) recapitulates the interferon-related (with upregulation of Oas family) and phagocytic microglia phenotypes (with an upregulation of Axl) that is sufficient to alter instrumental learning and memory, and LTP. Our findings reveal common microglia signatures in acute (LPS) and chronic (AD) inflammatory conditions both in mouse animal models and human AD. Depletion of RelA reprograms microglia towards a phenotype present in both the late state in acute LPS, and Aβ plaques-associated microglia in chronic disease. Our work deepens our knowledge of microglia heterogeneity in acute and chronic neuroinflammatory response, with major implications for our understanding of microglia contributions to disease., [ES] La heterogeneidad de la microglía ha sido demostrada tanto en el cerebro sano comoen condiciones patológicas. Sin embargo, los cambios en la accesibilidad de la cromatina y el perfil transcripcional de la microglía durante una inflamación aguda son poco conocidos. La combinación de RNA-sequencing y ATAC-sequencing en microglía aislada por FACS junto con ensayos de hibridación in situ (RNAscope), muestran que la microglía lleva a cabo transiciones dinámicas entre distintos estados funcionales a lo largo de la respuesta inflamatoria aguda. Hemos identificado una respuesta temprana-corta compuesta por genes relacionados con la respuesta de las citoquinas (Il1b) y una respuesta tempranasostenida compuesta por genes de la vía del interferón (Oasl2); una respuesta tardía y heterogénea asociada la función proliferativa de la microglía (Ms4a4a); y una respuesta tardía-sostenida relacionada con la expresión de MHC-II (Axl); al mismo tiempo, hay una disminución transitoria en la expresión de genes homeostáticos (P2ry12, Cx3cr1, entre otros). Tras meta-analizar datos publicados de marcadores de DAM microglía junto con los genes identificados en nuestro estudio con LPS, observamos que los marcadores que identifican a la microglía DAM son compartidos con los expresados por la microglía en los estadios tardíos de inflamación aguda. Confirmamos la presencia de DAM e IRM microglía en el modelo de AD J20 mediante single-cell RNA-sequencing de microglía aislada. Además, identificamos mediante RNAscope de marcadores comunes de neuroinflamación aguda y crónica un aumento en la expresión de Oasl2 en la proximidad de las placas β-amiloideas difusas, mientras que el aumento observado en la expresión de Axl ocurre tanto en placas β-amiloideas difusas como compactas. También mostramos un aumento en la expresión de Oasl2 y Axl en tejido post-mortem de pacientes con enfermedad de Alzheimer. Finalmente, hemos identificado, mediante un análisis in silico de motivos de unión de factores de transcripción, a la subunidad RelA/p65 del factor de transcripción NFκB como un regulador clave en la microglía del programa transcripcional relacionado con la expresión de citoquinas. La depleción condicional de RelA en la microglía durante la etapa adulta recapitula la respuesta relacionada con el interferón (con un aumento en la expresión de la familia Oas) y la fagocitosis (con un aumento en la expresión de Axl) que es suficiente para alterar el aprendizaje instrumental y la LTP. Nuestros hallazgos muestran estados comunes de la microglía en condiciones inflamatorias agudas (LPS) y crónicas (AD) tanto en modelos animales como en humano. La depleción selectiva de RelA reprograma a la microglía hacia un fenotipo presente tanto en los estados tardíos en la respuesta aguda a LPS como en enfermedad crónica. Nuestro trabajo aumenta el conocimiento actual sobre la heterogeneidad de la microglía en situaciones neuroinflamatorias agudas y crónicas lo que supone grandes implicaciones para nuestro entendimiento sobre cómo el papel que juega la microglía en diferentes patologías del CNS., The present PhD thesis has been funded by the following research agencies: Dña. Carmen María Navarrón Izquierdo is recipient of a FPI contract (BES-2016-076281) associated with the excellence program Severo Ochoa (SEV-2013-0317). The present PhD thesis has been supported by the grants SAF2014-60233-JIN RYC-2015-18056, and RTI2018-102260-BI00, from MICINN co-financed by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development and maintenance of the brain's immune toolkit: Microglia and non-parenchymal brain macrophages

  • López-Atalaya, José P.
  • Askew, Katharine E.
  • Sierra, Amanda
  • Gomez-Nicola, Diego
Microglia and non-parenchymal macrophages located in the perivascular space, the meninges and the choroid plexus are independent immune populations that play vital roles in brain development, homeostasis, and tissue healing. Resident macrophages account for a significant proportion of cells in the brain and their density remains stable throughout the lifespan thanks to constant turnover. Microglia develop from yolk sac progenitors, later evolving through intermediate progenitors in a fine-tuned process in which intrinsic factors and external stimuli combine to progressively sculpt their cell type-specific transcriptional profiles. Recent evidence demonstrates that non-parenchymal macrophages are also generated during early embryonic development. In recent years, the development of powerful fate mapping approaches combined with novel genomic and transcriptomic methodologies have greatly expanded our understanding of how brain macrophages develop and acquire specialized functions, and how cell population dynamics are regulated. Here, we review the transcription factors, epigenetic remodeling, and signaling pathways orchestrating the embryonic development of microglia and non-parenchymal macrophages. Next, we describe the dynamics of the macrophage populations of the brain and discuss the role of progenitor cells, to gain a better understanding of their functions in the healthy and diseased brain., Contract grant sponsor: Spanish Ministry of Economy and Competitiveness (MINECO) with European Regional Develop-ment Fund (ERDF) funds; contract grant numbers: BFU2015-66689, RYC-2013-12817.Contract grant sponsor: BBVA Foundation and a Basque Government; contract grant number: PI_2016_1_0011.Contract grant sponsor: “Ramon y Cajal” and European Social Fund (ESF) and national resources (MINEICO-AEI); contractgrant number: RYC-2015-18056.Contract grant sponsor: MINECO co-financed by the EuropeanRegional Development Fund (ERDF); contract grant number:SAF2014-60233-JIN.Contract grant sponsor: Instituto de Neurociencias is a “Centre ofExcellence Severo Ochoa”; contract grant number: SEV-2013-0317.Contract grant sponsor: Medical Research Council, Alzheimer’s Research UK and The Leverhulme Trust., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lack of IL-1r8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects

  • Tomasoni, Romana
  • Morini, Raffaella
  • López-Atalaya, José P.
  • Corradini, Irene
  • Canzi, Alice
  • Rasile, Marco
  • Mantovani, Cristina
  • Pozzi, Davide
  • Garlanda, Cecilia
  • Mantovani, Alberto
  • Menna, Elisabetta
  • Barco, Ángel
  • Matteoli, Michela
Inflammation modifies risk and/or severity of a variety of brain diseases through still elusive molecular mechanisms. Here we show that hyperactivation of the interleukin 1 pathway, through either ablation of the interleukin 1 receptor 8 (IL-1R8, also known as SIGIRR or Tir8) or activation of IL-1R, leads to up-regulation of the mTOR pathway and increased levels of the epigenetic regulator MeCP2, bringing to disruption of dendritic spine morphology, synaptic plasticity and plasticity-related gene expression. Genetic correction of MeCP2 levels in IL-1R8 KO neurons rescues the synaptic defects. Pharmacological inhibition of IL-1R activation by Anakinra corrects transcriptional changes, restores MeCP2 levels and spine plasticity and ameliorates cognitive defects in IL-1R8 KO mice. By linking for the first time neuronal MeCP2, a key player in brain development, to immune activation and demonstrating that synaptic defects can be pharmacologically reversed, these data open the possibility for novel treatments of neurological diseases through the immune system modulation., Work in our lab is supported by Cariplo 2012–0560, Ministero della Salute GR-2011–02347377, CARIPLO 2015–0594, to MM and by Cariplo 2015–0952 to RT. RT was previously supported by a Fondazione Umberto Veronesi Fellowship. IC is supported by a Fondazione Giancarla Vollaro Fellowship. JPLA is supported by grant SAF2014-60233-JIN from the Ministerio de Economia y Competitividad (MINECO) co-financed by the European Regional Development Fund (ERDF). AB is supported by grants SAF2014-56197-R, SEV-2013-0317 and PCIN-2015-192-C02-01 from MINECO co-financed by the European Regional Development Fund (ERDF). AM acknolewledges a grant from Fondazione Cariplo (Contract n. 2015- 0564., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Loss of Kdm5c causes spurious transcription and prevents the fine-tuning of activity-regulated enhancers in neurons

  • Scandaglia, Marilyn
  • López-Atalaya, José P.
  • Medrano-Fernandez, Alejandro
  • López-Cascales, María Teresa
  • Blanco, Beatriz del
  • Lipinski, Michal
  • Benito, Eva
  • Olivares, Román
  • Iwase, Shigeki
  • Shi, Yang
  • Barco, Ángel
During development, chromatin-modifying enzymes regulate both the timely establishment of cell-type-specific gene programs and the coordinated repression of alternative cell fates. To dissect the role of one such enzyme, the intellectual-disability-linked lysine demethylase 5C (Kdm5c), in the developing and adult brain, we conducted parallel behavioral, transcriptomic, and epigenomic studies in Kdm5c-null and forebrain-restricted inducible knockout mice. Together, genomic analyses and functional assays demonstrate that Kdm5c plays a critical role as a repressor responsible for the developmental silencing of germline genes during cellular differentiation and in fine-tuning activity-regulated enhancers during neuronal maturation. Although the importance of these functions declines after birth, Kdm5c retains an important genome surveillance role preventing the incorrect activation of non-neuronal and cryptic promoters in adult neurons., M.S. and A.M.-F. are recipients of “Formación de Personal Investigador” fellowships, and B.d.B. is the recipient of a “Juan de la Cierva – Incorporación” contract (all from the Spanish Ministry of Economy and Competitivity [MINECO]). J.P.L.-A.’s research is supported by a “Ramón y Cajal” contract and by grant SAF2014-60233-JIN from MINECO (co-financed by the European Regional Development Fund [ERDF]). A.B.’s research is supported by grants SAF2014-56197-R, PCIN-2015-192-C02-01 (part of the coordinated project ERA-Net NEURON8-2015), and SEV-2013-0317 from MINECO (co-financed by ERDF), grant PROMETEO/2016/006 from the Generalitat Valenciana, a NARSAD Independent Investigator grant (no. 21941) from the Brain & Behavior Research Foundation, and a grant from the Alicia Koplowitz Foundation. S.I.’s research is supported by NIH grant NS089896 and the Farrehi Family Foundation. KDM5C research in the Y.S. lab is supported by NIH grant MH096066. Y.S. is an American Cancer Society Research Professor. The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa.”, Peer reviewed